![Pharmaceuticals | Free Full-Text | Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease Pharmaceuticals | Free Full-Text | Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01330/article_deploy/html/images/pharmaceuticals-14-01330-g002-550.jpg)
Pharmaceuticals | Free Full-Text | Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
![Rational design of a conformation-specific antibody for the quantification of Aβ oligomers. - Abstract - Europe PMC Rational design of a conformation-specific antibody for the quantification of Aβ oligomers. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7306997/bin/pnas.1919464117fig02.jpg)
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers. - Abstract - Europe PMC
![PDF) Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease PDF) Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease](https://i1.rgstatic.net/publication/311899043_Systematic_development_of_small_molecules_to_inhibit_specific_microscopic_steps_of_Ab42_aggregation_in_Alzheimer's_disease/links/5864388708ae8fce490b73a6/largepreview.png)
PDF) Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
![Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method | Science Advances Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method | Science Advances](https://www.science.org/cms/10.1126/sciadv.1700488/asset/1ff17d07-a866-48a2-bace-2028f4e07c4c/assets/graphic/1700488-f1.jpeg)
Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method | Science Advances
![Two decades of new drug discovery and development for Alzheimer's disease - RSC Advances (RSC Publishing) DOI:10.1039/C6RA26737H Two decades of new drug discovery and development for Alzheimer's disease - RSC Advances (RSC Publishing) DOI:10.1039/C6RA26737H](https://pubs.rsc.org/image/article/2017/RA/c6ra26737h/c6ra26737h-f4_hi-res.gif)
Two decades of new drug discovery and development for Alzheimer's disease - RSC Advances (RSC Publishing) DOI:10.1039/C6RA26737H
![PDF) Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation PDF) Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation](https://i1.rgstatic.net/publication/342357550_Small_molecule-mediated_co-assembly_of_amyloid-b_oligomers_reduces_neurotoxicity_through_promoting_non-fibrillar_aggregation/links/60ca2a15458515dc178930f9/largepreview.png)
PDF) Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation
![A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41378-023-00485-4/MediaObjects/41378_2023_485_Fig1_HTML.png)
A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering
![An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances](https://www.science.org/cms/10.1126/sciadv.1501244/asset/e45b310d-9519-4678-8048-bc3a3d05710a/assets/graphic/1501244-f1.jpeg)
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances
![Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.2c00498/asset/images/large/cn2c00498_0004.jpeg)
Perphenazine–Macrocycle Conjugates Rapidly Sequester the Aβ42 Monomer and Prevent Formation of Toxic Oligomers and Amyloid | ACS Chemical Neuroscience
![Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer's Disease | ACS Chemical Neuroscience Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer's Disease | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.9b00297/asset/images/medium/cn9b00297_0007.gif)
Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer's Disease | ACS Chemical Neuroscience
![C-Terminal Fragment, Aβ39–42-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity | ACS Omega C-Terminal Fragment, Aβ39–42-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.8b01522/asset/images/large/ao-2018-01522t_0006.jpeg)
C-Terminal Fragment, Aβ39–42-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity | ACS Omega
![PDF) A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease PDF) A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease](https://i1.rgstatic.net/publication/344315383_A_rationally_designed_bicyclic_peptide_remodels_Ab42_aggregation_in_vitro_and_reduces_its_toxicity_in_a_worm_model_of_Alzheimer's_disease/links/5fb6b1aea6fdcc6cc64bda9d/largepreview.png)
PDF) A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer's disease
![IJMS | Free Full-Text | Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers IJMS | Free Full-Text | Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers](https://pub.mdpi-res.com/ijms/ijms-21-04542/article_deploy/html/images/ijms-21-04542-ag-550.jpg?1594042941)
IJMS | Free Full-Text | Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers
![PDF) Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method PDF) Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method](https://i1.rgstatic.net/publication/318336682_Selective_targeting_of_primary_and_secondary_nucleation_pathways_in_Ab42_aggregation_using_a_rational_antibody_scanning_method/links/59b7b3b4458515c212b4beca/largepreview.png)
PDF) Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
![A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41378-023-00485-4/MediaObjects/41378_2023_485_Fig3_HTML.png)
A spiral microfluidic device for rapid sorting, trapping, and long-term live imaging of Caenorhabditis elegans embryos | Microsystems & Nanoengineering
Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer's Disease | ACS Chemical Neuroscience
![An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances](https://www.science.org/cms/10.1126/sciadv.1501244/asset/c22c284c-f566-49be-9bf8-b610dd15688f/assets/graphic/1501244-f4.jpeg)
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances
![Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans | ACS Chemical Neuroscience Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.7b00361/asset/images/large/cn-2017-00361n_0001.jpeg)
Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans | ACS Chemical Neuroscience
![An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances](https://www.science.org/cms/10.1126/sciadv.1501244/asset/6a9da3ab-4406-4c93-970a-261d1aa0c271/assets/graphic/1501244-f6.jpeg)
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease | Science Advances
![PDF) Delivery of Native Proteins into C. Elegans Using a Transduction Protocol Based on Lipid Vesicles PDF) Delivery of Native Proteins into C. Elegans Using a Transduction Protocol Based on Lipid Vesicles](https://i1.rgstatic.net/publication/320932067_Delivery_of_Native_Proteins_into_C_Elegans_Using_a_Transduction_Protocol_Based_on_Lipid_Vesicles/links/5a0338e1a6fdcc6b7c9d1c45/largepreview.png)
PDF) Delivery of Native Proteins into C. Elegans Using a Transduction Protocol Based on Lipid Vesicles
![Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease | Science Advances Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease | Science Advances](https://www.science.org/cms/10.1126/sciadv.abb5924/asset/300c67db-5484-4057-a299-5bf8a3d4fd6b/assets/graphic/abb5924-f2.jpeg)